BioCentury
ARTICLE | Company News

Kos board of directors update

August 9, 2004 7:00 AM UTC

Kos Pharmaceuticals Inc. (KOSP), Miami, Fla. Business: Cardiovascular Appointed: Kevin Ferro, CEO and chief investment officer of Ferro Capital LLC ...